{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:32:16Z","timestamp":1792783936975,"version":"4.5.0"},"reference-count":90,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R56 AI117287"],"award-info":[{"award-number":["R56 AI117287"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["U19 AI109946"],"award-info":[{"award-number":["U19 AI109946"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Centers of Influenza Virus Research and Surveillance (CEIRS)","award":["HHSN272201400008C"],"award-info":[{"award-number":["HHSN272201400008C"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Virology"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.coviro.2016.02.002","type":"journal-article","created":{"date-parts":[[2016,2,27]],"date-time":"2016-02-27T11:30:36Z","timestamp":1456572636000},"page":"95-103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":102,"special_numbering":"C","title":["Novel universal influenza virus vaccine approaches"],"prefix":"10.1016","volume":"17","author":[{"given":"Florian","family":"Krammer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coviro.2016.02.002_bib0455","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1186\/s12879-014-0670-5","article-title":"Natural attack rate of influenza in unvaccinated children and adults: a meta-regression analysis","volume":"14","author":"Jayasundara","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.coviro.2016.02.002_bib0460","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1016\/S0264-410X(03)00071-9","article-title":"The annual production cycle for influenza vaccine","volume":"21","author":"Gerdil","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2016.02.002_bib0465","doi-asserted-by":"crossref","first-page":"20248","DOI":"10.1073\/pnas.1320524110","article-title":"Genome-wide mutagenesis of influenza virus reveals unique plasticity of the hemagglutinin and NS1 proteins","volume":"110","author":"Heaton","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2016.02.002_bib0470","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1126\/science.1171491","article-title":"Antibody recognition of a highly conserved influenza virus epitope","volume":"324","author":"Ekiert","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.coviro.2016.02.002_bib0475","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1126\/science.1204839","article-title":"A highly conserved neutralizing epitope on group 2 influenza A viruses","volume":"333","author":"Ekiert","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.coviro.2016.02.002_bib0480","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1126\/science.1205669","article-title":"A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins","volume":"333","author":"Corti","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.coviro.2016.02.002_bib0485","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nsmb.1566","article-title":"Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses","volume":"16","author":"Sui","year":"2009","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.coviro.2016.02.002_bib0490","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1128\/JVI.67.5.2552-2558.1993","article-title":"A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains","volume":"67","author":"Okuno","year":"1993","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.02.002_bib0495","doi-asserted-by":"crossref","first-page":"13580","DOI":"10.1128\/JVI.02289-14","article-title":"Characterization of a broadly neutralizing monoclonal antibody that targets the fusion domain of group 2 influenza a virus hemagglutinin","volume":"88","author":"Tan","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.02.002_bib0500","doi-asserted-by":"crossref","first-page":"6179","DOI":"10.1128\/JVI.00469-12","article-title":"A pan-h1 anti-hemagglutinin monoclonal antibody with potent broad-spectrum efficacy in vivo","volume":"86","author":"Tan","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.02.002_bib0505","doi-asserted-by":"crossref","first-page":"e1000796","DOI":"10.1371\/journal.ppat.1000796","article-title":"Broadly protective monoclonal antibodies against H3 influenza viruses following sequential immunization with different hemagglutinins","volume":"6","author":"Wang","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2016.02.002_bib0510","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1172\/JCI74374","article-title":"Preexisting human antibodies neutralize recently emerged H7N9 influenza strains","volume":"125","author":"Henry Dunand","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coviro.2016.02.002_bib0515","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.chom.2015.10.003","article-title":"The quest for a universal flu vaccine: headless HA 2.0","volume":"18","author":"Krammer","year":"2015","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.coviro.2016.02.002_bib0520","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.coviro.2013.07.007","article-title":"Influenza virus hemagglutinin stalk-based antibodies and vaccines","volume":"3","author":"Krammer","year":"2013","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.coviro.2016.02.002_bib0525","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/0042-6822(83)90465-8","article-title":"Preparation of influenza virus subviral particles lacking the HA1 subunit of hemagglutinin: unmasking of cross-reactive HA2 determinants","volume":"126","author":"Graves","year":"1983","journal-title":"Virology"},{"issue":"Pt 7","key":"10.1016\/j.coviro.2016.02.002_bib0530","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1099\/0022-1317-77-7-1483","article-title":"The immunological activity of a deletion mutant of influenza virus haemagglutinin lacking the globular region","volume":"77","author":"Sagawa","year":"1996","journal-title":"J Gen Virol"},{"key":"10.1016\/j.coviro.2016.02.002_bib0535","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/mBio.00018-10","article-title":"Influenza virus vaccine based on the conserved hemagglutinin stalk domain","volume":"1","author":"Steel","year":"2010","journal-title":"MBio"},{"key":"10.1016\/j.coviro.2016.02.002_bib0540","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1016\/j.vaccine.2015.05.038","article-title":"Vaccination with soluble headless hemagglutinin protects mice from challenge with divergent influenza viruses","volume":"33","author":"Wohlbold","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2016.02.002_bib0545","doi-asserted-by":"crossref","first-page":"13701","DOI":"10.1073\/pnas.1007465107","article-title":"Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge","volume":"107","author":"Bommakanti","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2016.02.002_bib0550","doi-asserted-by":"crossref","first-page":"13434","DOI":"10.1128\/JVI.01429-12","article-title":"Design of Escherichia coli-expressed stalk domain immunogens of H1N1 hemagglutinin that protect mice from lethal challenge","volume":"86","author":"Bommakanti","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.02.002_bib0555","doi-asserted-by":"crossref","first-page":"E2514","DOI":"10.1073\/pnas.1402766111","article-title":"Influenza hemagglutinin stem-fragment immunogen elicits broadly neutralizing antibodies and confers heterologous protection","volume":"111","author":"Mallajosyula","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2016.02.002_sbref0560","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1073\/pnas.1308701110","article-title":"Production and stabilization of the trimeric influenza hemagglutinin stem domain for potentially broadly protective influenza vaccines","volume":"111","author":"Lu","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2016.02.002_sbref0565","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/nm.3927","article-title":"Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection","volume":"21","author":"Yassine","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.coviro.2016.02.002_sbref0570","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1126\/science.aac7263","article-title":"A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen","volume":"349","author":"Impagliazzo","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.coviro.2016.02.002_bib0575","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/ni.2761","article-title":"Universal influenza virus vaccines: need for clinical trials","volume":"15","author":"Krammer","year":"2014","journal-title":"Nat Immunol"},{"key":"10.1016\/j.coviro.2016.02.002_bib0580","first-page":"301","article-title":"Advances in universal influenza virus vaccine design and antibody mediated therapies based on conserved regions of the hemagglutinin","volume":"386","author":"Krammer","year":"2015","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.coviro.2016.02.002_bib0585","doi-asserted-by":"crossref","first-page":"5774","DOI":"10.1128\/JVI.00137-12","article-title":"Influenza viruses expressing chimeric hemagglutinins: globular head and stalk domains derived from different subtypes","volume":"86","author":"Hai","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.02.002_bib0590","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1073\/pnas.1200039109","article-title":"Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses","volume":"109","author":"Pica","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2016.02.002_bib0595","article-title":"Influenza A viruses expressing intra- or inter-group chimeric hemagglutinins","author":"Chen","year":"2016","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.02.002_sbref0600","doi-asserted-by":"crossref","first-page":"6542","DOI":"10.1128\/JVI.00641-13","article-title":"Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies","volume":"87","author":"Krammer","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.02.002_bib0605","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1128\/JVI.03183-13","article-title":"H3 stalk-based chimeric hemagglutinin influenza virus constructs protect mice from H7N9 challenge","volume":"88","author":"Krammer","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.02.002_bib0610","doi-asserted-by":"crossref","first-page":"10435","DOI":"10.1128\/JVI.01715-13","article-title":"Hemagglutinin stalk-based universal vaccine constructs protect against group 2 influenza A viruses","volume":"87","author":"Margine","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.02.002_bib0615","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1128\/JVI.03004-13","article-title":"Assessment of influenza virus hemagglutinin stalk-based immunity in ferrets","volume":"88","author":"Krammer","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.02.002_bib0620","doi-asserted-by":"crossref","first-page":"e79194","DOI":"10.1371\/journal.pone.0079194","article-title":"Adjuvants and immunization strategies to induce influenza virus hemagglutinin stalk antibodies","volume":"8","author":"Goff","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.coviro.2016.02.002_bib0625","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1128\/JVI.02598-15","article-title":"Vaccination with VSV-vectored chimeric hemagglutinins protects mice against divergent influenza virus challenge strains","volume":"90","author":"Ryder","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.02.002_bib0630","article-title":"Hemagglutinin stalk immunity reduces influenza virus replication and transmission in ferrets","author":"Nachbagauer","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.02.002_bib0635","first-page":"7","article-title":"Age dependence and isotype specificity of influenza virus hemagglutinin stalk-reactive antibodies in humans","author":"Nachbagauer","year":"2016","journal-title":"MBio"},{"key":"10.1016\/j.coviro.2016.02.002_sbref0640","doi-asserted-by":"crossref","first-page":"13133","DOI":"10.1073\/pnas.1414070111","article-title":"Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans","volume":"111","author":"Ellebedy","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2016.02.002_sbref0645","doi-asserted-by":"crossref","first-page":"13260","DOI":"10.1128\/JVI.02133-14","article-title":"Induction of broadly reactive anti-hemagglutinin stalk antibodies by an H5N1 vaccine in humans","volume":"88","author":"Nachbagauer","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.02.002_bib0650","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1128\/CVI.00735-12","article-title":"B cell response and hemagglutinin stalk-reactive antibody production in different age cohorts following 2009 H1N1 influenza virus vaccination","volume":"20","author":"Sangster","year":"2013","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.coviro.2016.02.002_bib0655","doi-asserted-by":"crossref","first-page":"4728","DOI":"10.1128\/JVI.03509-12","article-title":"H3N2 influenza virus infection induces broadly reactive hemagglutinin stalk antibodies in humans and mice","volume":"87","author":"Margine","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.02.002_bib0660","doi-asserted-by":"crossref","first-page":"10302","DOI":"10.1128\/JVI.01336-12","article-title":"Hemagglutinin stalk-reactive antibodies are boosted following sequential infection with seasonal and pandemic H1N1 influenza virus in mice","volume":"86","author":"Krammer","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.02.002_bib0665","doi-asserted-by":"crossref","first-page":"198ra107","DOI":"10.1126\/scitranslmed.3006637","article-title":"Neutralizing antibodies against previously encountered influenza virus strains increase over time: a longitudinal analysis","volume":"5","author":"Miller","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coviro.2016.02.002_sbref0670","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1093\/infdis\/jiv210","article-title":"High-affinity H7 head and stalk domain-specific antibody responses to an inactivated influenza H7N7 vaccine after priming with live attenuated influenza vaccine","volume":"212","author":"Halliley","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2016.02.002_bib0675","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1128\/CVI.00272-14","article-title":"An H7N1 influenza virus vaccine induces broadly reactive antibody responses against H7N9 in humans","volume":"21","author":"Krammer","year":"2014","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.coviro.2016.02.002_bib0680","doi-asserted-by":"crossref","first-page":"9047","DOI":"10.1073\/pnas.1118979109","article-title":"Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells","volume":"109","author":"Li","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2016.02.002_bib0685","doi-asserted-by":"crossref","DOI":"10.1084\/jem.201013522082c","article-title":"Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection","author":"Wrammert","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.coviro.2016.02.002_bib0690","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/infdis\/jis652","article-title":"and 2009 H1N1 influenza virus vaccines boost anti-hemagglutinin stalk antibodies in humans","volume":"207","author":"Miller","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2016.02.002_bib0695","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3389\/fimmu.2012.00087","article-title":"Pandemic H1N1 influenza infection and vaccination in humans induces cross-protective antibodies that target the hemagglutinin stem","volume":"3","author":"Thomson","year":"2012","journal-title":"Front Immunol"},{"key":"10.1016\/j.coviro.2016.02.002_bib0700","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad0522","article-title":"Immune history profoundly affects broadly protective B cell responses to influenza","volume":"7","author":"Andrews","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coviro.2016.02.002_bib0705","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025797","article-title":"H3N2 influenza infection elicits more cross-reactive and less clonally expanded anti-hemagglutinin antibodies than influenza vaccination","volume":"6","author":"Moody","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.coviro.2016.02.002_bib0710","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nature06890","article-title":"Rapid cloning of high-affinity human monoclonal antibodies against influenza virus","volume":"453","author":"Wrammert","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2016.02.002_bib0715","doi-asserted-by":"crossref","first-page":"11686","DOI":"10.1128\/JVI.01694-12","article-title":"A virus-like particle that elicits cross-reactive antibodies to the conserved stem of influenza virus hemagglutinin","volume":"86","author":"Schneemann","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.02.002_bib0720","first-page":"901817","article-title":"Protection against multiple subtypes of influenza viruses by virus-like particle vaccines based on a hemagglutinin conserved epitope","volume":"2015","author":"Chen","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.coviro.2016.02.002_bib0725","doi-asserted-by":"crossref","first-page":"18979","DOI":"10.1073\/pnas.1013387107","article-title":"Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes","volume":"107","author":"Wang","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2016.02.002_bib0730","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4149\/av_2011_01_61","article-title":"Heterosubtypic protective immunity against influenza A virus induced by fusion peptide of the hemagglutinin in comparison to ectodomain of M2 protein","volume":"55","author":"Stanekov\u00e1","year":"2011","journal-title":"Acta Virol"},{"key":"10.1016\/j.coviro.2016.02.002_bib0735","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1128\/JVI.02608-13","article-title":"Guiding the immune response against influenza virus hemagglutinin toward the conserved stalk domain by hyperglycosylation of the globular head domain","volume":"88","author":"Eggink","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.02.002_bib0740","doi-asserted-by":"crossref","first-page":"e92822","DOI":"10.1371\/journal.pone.0092822","article-title":"Glycan masking of hemagglutinin for adenovirus vector and recombinant protein immunizations elicits broadly neutralizing antibodies against H5N1 avian influenza viruses","volume":"9","author":"Lin","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.coviro.2016.02.002_bib0745","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1126\/science.1192517","article-title":"Induction of broadly neutralizing H1N1 influenza antibodies by vaccination","volume":"329","author":"Wei","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.coviro.2016.02.002_bib0750","doi-asserted-by":"crossref","first-page":"6798","DOI":"10.1016\/j.vaccine.2014.09.070","article-title":"Live attenuated H7N7 influenza vaccine primes for a vigorous antibody response to inactivated H7N7 influenza vaccine","volume":"32","author":"Babu","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2016.02.002_bib0755","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiv210","article-title":"High-Affinity H7 head and stalk domain-specific antibody responses to an inactivated influenza H7N7 vaccine after priming with live attenuated influenza vaccine","author":"Halliley","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2016.02.002_bib0760","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1586\/14760584.2014.922416","article-title":"Improving pandemic H5N1 influenza vaccines by combining different vaccine platforms","volume":"13","author":"Luke","year":"2014","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.coviro.2016.02.002_bib0765","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1093\/infdis\/jiu123","article-title":"A live attenuated influenza A(H5N1) vaccine induces long-term immunity in the absence of a primary antibody response","volume":"209","author":"Talaat","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2016.02.002_bib0770","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/infdis\/jis652","article-title":"1976 and 2009 H1N1 influenza virus vaccines boost anti-hemagglutinin stalk antibodies in humans","volume":"207","author":"Miller","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2016.02.002_bib0775","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.1128\/JVI.03099-14","article-title":"Broadly neutralizing anti-influenza virus antibodies: enhancement of neutralizing potency in polyclonal mixtures and IgA backbones","volume":"89","author":"He","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.02.002_sbref0780","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nm.3443","article-title":"Broadly neutralizing hemagglutinin stalk-specific antibodies require Fc\u03b3R interactions for protection against influenza virus in vivo","volume":"20","author":"Dilillo","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.coviro.2016.02.002_bib0785","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1084\/jem.20101352","article-title":"Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection","volume":"208","author":"Wrammert","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.coviro.2016.02.002_bib0790","first-page":"179","article-title":"The relationship of race, sex, and age to concentrations of serum immunoglobulins expressed in international units in healthy adults in the USA","volume":"52","author":"Maddison","year":"1975","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.coviro.2016.02.002_bib0795","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1365-2249.2007.03545.x","article-title":"Serum levels of immunoglobulins (IgG, IgA, IgM) in a general adult population and their relationship with alcohol consumption, smoking and common metabolic abnormalities","volume":"151","author":"Gonzalez-Quintela","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.coviro.2016.02.002_bib0800","first-page":"101","article-title":"Serum immunoglobulin levels in healthy children and adults","volume":"4","author":"Stoop","year":"1969","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.coviro.2016.02.002_bib0805","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1002\/eji.1830191223","article-title":"Serum immunoglobulin levels and naturally occurring antibodies against carbohydrate antigens in germ-free BALB\/c mice fed chemically defined ultrafiltered diet","volume":"19","author":"Bos","year":"1989","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.coviro.2016.02.002_bib0810","first-page":"861","article-title":"Quantitative estimations of five classes of immunoglobulin in inbred mouse strains","volume":"32","author":"Natsuume-Sakai","year":"1977","journal-title":"Immunology"},{"key":"10.1016\/j.coviro.2016.02.002_bib0815","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1742-4682-11-30","article-title":"Comparative analysis of human and mouse immunoglobulin variable heavy regions from IMGT\/LIGM-DB with IMGT\/HighV-QUEST","volume":"11","author":"Shi","year":"2014","journal-title":"Theor Biol Med Model"},{"key":"10.1016\/j.coviro.2016.02.002_bib0820","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1126\/science.1222908","article-title":"Highly conserved protective epitopes on influenza B viruses","volume":"337","author":"Dreyfus","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.coviro.2016.02.002_sbref0825","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1128\/JVI.02275-15","article-title":"Hemagglutinin stalk- and neuraminidase-specific monoclonal antibodies protect against lethal H10N8 influenza virus infection in mice","volume":"90","author":"Wohlbold","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.02.002_bib0830","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01219-14","article-title":"Modified vaccinia Ankara encoding influenza virus hemagglutinin induces heterosubtypic immunity in macaques","author":"Florek","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.02.002_sbref0835","doi-asserted-by":"crossref","first-page":"5512","DOI":"10.1128\/JVI.03030-12","article-title":"Antibody-dependent cellular cytotoxicity is associated with control of pandemic H1N1 influenza virus infection of macaques","volume":"87","author":"Jegaskanda","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.02.002_sbref0840","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.4049\/jimmunol.1201574","article-title":"Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity antibodies in the absence of neutralizing antibodies","volume":"190","author":"Jegaskanda","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.coviro.2016.02.002_bib0845","doi-asserted-by":"crossref","first-page":"469","DOI":"10.4049\/jimmunol.1400432","article-title":"Influenza-specific antibody-dependent cellular cytotoxicity: toward a universal influenza vaccine","volume":"193","author":"Jegaskanda","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.coviro.2016.02.002_bib0850","doi-asserted-by":"crossref","first-page":"13463","DOI":"10.1128\/JVI.05193-11","article-title":"Complement-dependent lysis of influenza a virus-infected cells by broadly cross-reactive human monoclonal antibodies","volume":"85","author":"Terajima","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.02.002_bib0855","doi-asserted-by":"crossref","first-page":"e1003207","DOI":"10.1371\/journal.ppat.1003207","article-title":"Cooperativity between CD8+ T cells, non-neutralizing antibodies, and alveolar macrophages is important for heterosubtypic influenza virus immunity","volume":"9","author":"Laidlaw","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2016.02.002_bib0860","doi-asserted-by":"crossref","first-page":"e3942","DOI":"10.1371\/journal.pone.0003942","article-title":"Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells","volume":"3","author":"Throsby","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.coviro.2016.02.002_bib0865","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1073\/pnas.1319058110","article-title":"A common solution to group 2 influenza virus neutralization","volume":"111","author":"Friesen","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2016.02.002_bib0870","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.chom.2013.06.004","article-title":"An in vivo human-plasmablast enrichment technique allows rapid identification of therapeutic influenza A antibodies","volume":"14","author":"Nakamura","year":"2013","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.coviro.2016.02.002_bib0875","doi-asserted-by":"crossref","first-page":"7708","DOI":"10.1038\/ncomms8708","article-title":"A potent broad-spectrum protective human monoclonal antibody crosslinking two haemagglutinin monomers of influenza A virus","volume":"6","author":"Wu","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.coviro.2016.02.002_bib0880","doi-asserted-by":"crossref","first-page":"10890","DOI":"10.1073\/pnas.1502374112","article-title":"A broadly neutralizing human monoclonal antibody is effective against H7N9","volume":"112","author":"Tharakaraman","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2016.02.002_bib0885","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.vaccine.2014.06.052","article-title":"Waning vaccine protection against influenza A (H3N2) illness in children and older adults during a single season","volume":"33","author":"Belongia","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2016.02.002_bib0890","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/nature07231","article-title":"Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors","volume":"455","author":"Yu","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2016.02.002_bib0895","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1128\/JVI.03337-14","article-title":"Synthetic Toll-like receptor 4 (TLR4) and TLR7 ligands as influenza virus vaccine adjuvants induce rapid, sustained, and broadly protective responses","volume":"89","author":"Goff","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.02.002_bib0900","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1126\/science.1093155","article-title":"The structure and receptor binding properties of the 1918 influenza hemagglutinin","volume":"303","author":"Gamblin","year":"2004","journal-title":"Science"}],"container-title":["Current Opinion in Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625716300062?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625716300062?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T01:18:10Z","timestamp":1600219090000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879625716300062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":90,"alternative-id":["S1879625716300062"],"URL":"https:\/\/doi.org\/10.1016\/j.coviro.2016.02.002","relation":{},"ISSN":["1879-6257"],"issn-type":[{"value":"1879-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel universal influenza virus vaccine approaches","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coviro.2016.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}